720-777-0123
- Your Visit
-
Research & Innovation
It starts with a Q:
For the latest cutting-edge research, innovative collaborations and remarkable discoveries in child health, read stories from across all our areas of study in Q: Advances and Answers in Pediatric Health.
University of Colorado Health Blood Disorders and Cell Therapies Center - Anschutz Medical Campus
In order to provide the best-level of care, exquisite attention to detail is needed, as there are many factors that are often overlooked or disregarded in patients with bleeding or thrombotic disorders. I strive to know these facts about a patient's history so that clinically relevant information is not missed.
Get to know Ara Metjian, MD
- Bleeding Disorders
- Blood Disorders
- Clotting Disorders
Undergraduate 1995
Bucknell University (PA)
Residency 1999
University of North Carolina at Chapel Hill Program
Medical Education 2001
Drexel University College of Medicine
Internship 2001
University of North Carolina at Chapel Hill Program
Fellowship 2005
University of Pennsylvania Program
Fellowship 2008
Duke University Hospital Program
For Patients:
I have an active interest in all aspects of Benign Hematology, particularly in congenital bleeding disorders and acquired diseases of hemostasis, such as thrombotic microangiopathies and immune-mediated cytopenias. These conditions are rare and often occur in under-represented populations, which makes their research and development even more necessary. By offering a wide array of clinical trials for these disease states, we can move care forward and offer improved therapies
I have an active interest in all aspects of Benign Hematology, particularly in congenital bleeding disorders and acquired diseases of hemostasis, such as thrombotic microangiopathies and immune-mediated cytopenias. These conditions are rare and often occur in under-represented populations, which makes their research and development even more necessary. By offering a wide array of clinical trials for these disease states, we can move care forward and offer improved therapies
For Referring Providers:
My research interests run the entire gamut of Benign Hematology, particularly as many of these conditions are uncommon or rare, and often enough, under-represented. By bringing clinical trials to these patients, this is a way to improve care for our patients.
My research interests run the entire gamut of Benign Hematology, particularly as many of these conditions are uncommon or rare, and often enough, under-represented. By bringing clinical trials to these patients, this is a way to improve care for our patients.
Stephen Hawkins, MD
Pulmonology - Pediatric, Pediatrics, Sleep Medicine
Derek Samples, MD
Neurosurgery
